Bibliografia
Giannini S, Mazzaferro S, Minisola S et al. (2018) Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion. Endocrine 59(2):242–259
Ketteler M, Block GA, Evenepoel P et al. (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int 92:26–36
Alfieri C, Ruzhytska O, Vettoretti S et al. (2019) Native hypovitaminosis D in CKD patients: from experimental evidence to clinical practice. Nutrients 11:E1918
Melamed ML, Chonchol M, Gutiérrez OM et al. (2018) The role of vitamin D in CKD stages 3 to 4: report of a scientific workshop sponsored by the National Kidney Foundation. Am J Kidney Dis 72:834–845
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
L’autrice Sabrina Corbetta dichiara di non avere conflitti di interesse.
Consenso informato
Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.
Studi sugli animali
L’autrice di questo articolo non ha eseguito studi sugli animali.
Additional information
Nota della casa editrice
Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.
Rights and permissions
About this article
Cite this article
Corbetta, S. Ipovitaminosi D nel paziente nefropatico. L'Endocrinologo 21, 367–369 (2020). https://doi.org/10.1007/s40619-020-00781-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-020-00781-5